Trials / Completed
CompletedNCT02245789
Does the Use of a Videolaryngoscope Modifies Anesthetic Induction ?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Videolaryngoscopes become widely used. The aim of this study is to compare anesthetic induction when patients are tracheally intubated using a MacGraph Mac videolaryngoscope or a conventional MacIntosh laryngoscope. Tracheal intubation induces a nociceptive stimulation. Hypothesis is that the use of a videolaryngoscope induces a less pronounced nociceptive stimulation and, consequently, that it modifies the anesthetic drugs requirement. .
Detailed description
All patients will received a standardized anesthetic procedure : combined closed-loop anesthesia system using bispectral index as control variable and two proportional-differential control algorithms, a propofol and a remifentanil target-controlled infusion system. The effectiveness of such a closed-loop anesthesia system has been demonstrated in a prospective, randomized study. Patients will be randomized in two groups : intubation using a conventional MacIntosh laryngoscope or intubation using a videolaryngoscope. If our hypothesis is confirmed, the required concentration of remifentanil, an opioid agent, will be reduced in the group using a videolaryngoscope.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tracheal intubation | Tracheal intubation will be performed using a Macintosh laryngoscope or a McGrath Mac videolaryngoscope |
| DRUG | Propofol and remifentanil anesthesia | The standardized anesthetic procedure used a closed-loop anesthesia system with bispectral index as control variable and with two proportional-differential control algorithms, one for propofol target-controlled infusion system and one for remifentanil target-controlled infusion system. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-09-22
- Last updated
- 2016-10-31
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02245789. Inclusion in this directory is not an endorsement.